Vidarabine phosphate

Overview

Vidarabine phosphate (ara-AMP; ara-A 5'-monophosphate) is a purine nucleoside antiviral agent and a prodrug of Vidarabine ( HY-B0277 ). Vidarabine phosphate is rapidly converted into the antiviral active Vidarabine in vivo, which selectively inhibits viral DNA polymerase and cellular ribonucleotide reductase, thereby blocking viral replication. Vidarabine phosphate also exhibits antifungal activity, induces late-stage cellular apoptosis , and causes cell cycle arrest. Vidarabine phosphate can be used in research related to severe chronic active Epstein-Barr virus ( EBV ) infection , herpes infection , and candidiasis.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Fungal Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Candida Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Others | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Signaling Pathways > HSV | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Drug Intermediate | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > EBV

Product Information

• Catalog No.: HY-B0277A
• CAS No.: 29984-33-6
• Molecular Formula: C10H14N5O7P
• Molecular Weight: 347.22
• Purity: 99.44%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 1.67 mg/mL (4.81 mM); Clear solution
• Availability: In-stock

Source

Original product source